Introducing HPV vaccine in developing countries--key challenges and issues

N Engl J Med. 2007 May 10;356(19):1908-10. doi: 10.1056/NEJMp078053.
No abstract available

MeSH terms

  • Adolescent
  • Adolescent Health Services
  • Alphapapillomavirus*
  • Cost-Benefit Analysis
  • Developing Countries*
  • Drug Costs
  • Female
  • Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
  • Humans
  • Papillomavirus Infections / prevention & control*
  • Papillomavirus Vaccines* / economics
  • Uterine Cervical Neoplasms / epidemiology
  • Uterine Cervical Neoplasms / prevention & control*

Substances

  • Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
  • Papillomavirus Vaccines
  • human papillomavirus vaccine, L1 type 16, 18